* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Drug interaction of plasma protein binding
Survey
Document related concepts
Discovery and development of proton pump inhibitors wikipedia , lookup
Polysubstance dependence wikipedia , lookup
Orphan drug wikipedia , lookup
Compounding wikipedia , lookup
Psychopharmacology wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Plateau principle wikipedia , lookup
Pharmacognosy wikipedia , lookup
Pharmacogenomics wikipedia , lookup
Neuropharmacology wikipedia , lookup
Pharmaceutical industry wikipedia , lookup
Drug design wikipedia , lookup
Drug discovery wikipedia , lookup
Prescription costs wikipedia , lookup
Transcript
Drugs and the Kidney Jin Wang Institute of Pharmacology School of Medicine Shandong University [email protected] Introduction Renal dysfunction may affect clearance and distribution of drugs. eg. phenobarbital Drugs may directly influence renal function. eg. dopamine Eeffect of renal impairment on drug excretion The Processes of Drug in the Body receptor B tissue free F bound circulation absorption excretion Free drug Bound drug metabolism metabolites The Drug Processes in the Body The Classifications Absorption吸收 Distribution分布 Metabolism代谢 Excretion排泄 Disposition处置:transportation and transformation Elimination消除:metabolism and excretion First-order Elimination Kinetics 一级消除动力学 The character of first-order kinetics is that the rate of elimination is directly proportional to the drug dose (linear relationship), here the half-life time keeps constant and has nothing to do with the amount of drug in the body. Most drug are eliminated with this kind of kinetics in their metabolism capacity. Zero-order Elimination Kinetics 零级消除动力学 The character of zero-order kinetics is that the rate of elimination is constant, i.e., independent of drug doses, and that the halflife time is positively relates to the drug doses. When the concentration of drug exceeds the capacity of the metabolism of the body, the drug is eliminated with zero-order kinetics. And then turn to the first-order kinetics elimination. Minimum effective concentration (MEC) The concentration inducing the minimal effect. Minimum toxic concentration (MTC) Elimination half-life time(t1/2): The time required for any given drug concentration in plasma to decrease by half. Time–Concentration (effect) Curve 时–量(效)曲线 Transportation of Drug Molecules Modes of transportation转运方式 (1) Filtration滤过 (2) Simple diffusion简单扩散 (down hill) Passive transport被动转运 No need for energy, carrier. No saturation limited. No competitive inhibition. Passive Transport by Factors Affected by properties, areas of membrane, concentration between memb., and properties of drug: molecular size, lipid solubility, polarity. Ion trapping(离子障): non-ionic drug is free to penetrate while ionic drug is limited to one side of the biomembrane. Transports of weak acidic and weak basic drug by Handerson-Hasselbalch Equation Weak acidic drug weak basic drug HA ≒ H+ + ABH+ ≒ H+ + B Ka = H+A-/HA Ka = H+B/BH+ pKa = A-/HA pKa = H+B/BH+ pKa = pH - logA-/HA pKa=pH-logB/BH+ pH–pKa=logA-/HA pK –pH=logBH+/B when pH = pKa, A- = HA B = BH+ Transports of weak acidic and weak basic drug by Handerson-Hasselbalch Equation pH–pKa=logA-/HA [HA]/[A-] = 10pka-pH [A-]/[HA] = 10pH-pka pK – pH=logBH+/B BH+/B = 10pka-pH question Aspirin PKa=3.5, PH (Stomach) =1.5,PH(blood)=7.5 ,PH (urine) =6.5 The extent of dissociation in stomach? The extent of dissociation in blood? (Drug in blood) /(drug in stomach)? (Drug in blood) /(drug in urine)? Absorption The movement of a drug from its site of administration into the blood circulation. The pathways of absorption Gastroentestinal pathway Steps:gastric stasis,gastric acidity, concurrent treatment drugs Distribution Conception The process by which a drug leaves the blood circulation to enter the extracellular fluids and the tissues of the body. Parameters of kinetics Apparent volume of distribution (表观分布容积, Vd) Vd means that the ratio of in vivo drug quantity verses concentration in plasma when the drug reaches the dynamic equilibrium in the body. Vd = A/C0 = A/AUC x Ke(L) Apparent volume of distribution For instance, if the Vd of a drug is about 3-5L, this drug may mainly distribute in the blood. If the Vd of a drug is about 10-20L, the drug chiefly distributing in plasma and extacellular fluid. And if a drug has the Vd of 40L, the drug could distribute in extra-cellular and intracellular fluids, indicating its widespread distribution in whole body. Importances of Vd Vd: 5L(plasma), 10~20L(systemic fluid), > 40L(tissue and organs), >100L(concentrate in some organ or large area of tissue) a 70kg male, blood volume is 5.5L, plasma 3L , extracellular fluid is 12L, total body fluids about 42L, Vd of aspirin is 11L, diazepam 80L, morphine 230L. Factors Affecting Drug Distribution a. Plasma protein binding血浆蛋白结合 Acidic drug-albumin, basic drug-albumin, lipoptrotein, and 1 acidic glycoprotein. D ≒ D + P ≒ DP Free drug bound drug Plasma Protein Binding Rate(PPBR) The fraction of drug binding to plasma protein to amount of drug in the body: The extent of combination of drugs with plasma protein differs, which is usually expressed by the ratio of the concentration of bound drug over total drug in the body, i.e., PPBR. Plasma Protein Binding Reversibility Inactivation Molecule bigger Unmetabolized No transmembrane Capacity-limited protein binding Replacement Drug interaction of plasma protein binding Drug A: 1000 molecules + Drug B with 94% bound 99.9% bound 1 molecules free 90.0% bound 100 molecules free 100-fold increase in free pharmacologically active concentration at site of action. Effective TOXIC Plasma Protein Binding Replacement Anticoagulant warfarin with PPBR of 99%, an anti-inflammatory agent, phenylbutazone with PPBR of 98%, when the two drugs are used at the same time, the replacement may occur, and eventually bleeding tendency due to the high free warfarin. Organ blood flow The more blood flow of tissue and organ, the more drugs go to these tissues or organs. Such as liver, brain, kidney and lung. Organ blood flow Some higher lipid-solubility drug first go to the abundant blood flow tissue or organ and then go to the much poor blood flow tissue or organ, such as thiopental first go to brain, and then go to muscle or other lipid tissue to form new equilibrium called redistribution. The properties of drug and physical pH The pH of body fluid may influence the extent of dissociation of drugs and thus affect the distribution and transport of drugs in the body. The properties of drug and physical pH The pH of cellular fluid is 7.0 and that of extracellular fluid is 7.4 under physiological circumstances, so the concentration of weak acidic drugs in extracellular fluid is higher than that in cellular fluid. The properties of drug and physical pH Reducing the pH of the blood can transfer weak acidic drugs into cells, while decreasing the pH of the blood can cause right-about transfer of acidic drugs. The situation for weak basic drugs is opposite. The properties of drug and physical pH Pentobarbital is a weak acidic drug, when it is used overdose and intoxication, the sodium bicarbonate may used to base the blood and urine to increase the excretion of pentobarbital and to anti-toxicant. Metabolism (Biotransformation) The process in which drugs result in chemical changes, that may lead to the termination or alternation of biological activity. it is also called biotransformation of drug in the body. The metabolism and excretion of drugs are generally called elimination. Cytochrome P450 (P450) Enzyme induction Enzyme inhibition Enzyme inducer: phenobarbital, rifampin, carbamazepine, phenytoin sodium, dexamethasone Enzyme inhibitor: chloramphenicol, ketoconazole, cimetidine Excretion of Drug The process in which of their prototype and their metabolites transferred from the internal to the external environment of body. The pathways of excretion includes: renal peptic, respiratory and milk excretion. The pathways of excretion Kidney肾脏 Glomerular filtration: accumulation Active tubular secretion: Probenecid丙磺舒 – penicillin Passive tubular reabsorption phenobarbital – sodium bicarbonate MTC MEC 稳态 约经5个半衰期达 到STEADY STATE 血 药 浓 度 稳态浓度 与给药间隔和剂量相关 与生物利用度和清除率相关 时间(半衰期) 靶浓度(target concentration) 有效而不产生毒性反应的稳态血浆药物浓度(Css) Css-max < MTC Css-min > MEC Characteristics of drugs that predict that a dosage adjustment should be made in renal disease Primary urinary excretion of the parent drug or active metabolites >50% Low therapeutic index Therapeutic index (TI) = LD50/ED50 High protein binding Small volume of distribution of the drug Renal impairment induced by drugs Antipyretic-analgesic and antiinflammatory drugs non-steroidal anti-inflammatory drugs (NSAIDs) Aspirin-like drugs Membrane phospholipids PLA2 Arachidonic acid NSAIDs PGG2 glucocorticoid COX PGH2 PGI2 PGF2 PGE2 TXA2 (vascular (bronchial (vascular dilation; (vascular dilation; constriction) GI protection; constriction; platelet pain,fever) thrombosis) disaggregate; pain) lipoxygenase LTs LTC4/ D4/E4 Bronchial constriction ; Alteration of vascular permeability LTB4 chemotaxis COX-1 Production Function Constitutive Physiological function gastric protection platelet aggregation COX-2 Inducible Pathological function facilitate inflammation cause fever and pain peripheral vessel regulation renal blood distribution NASIDs effects unwanted side effects therapeutic effects Nephrotoxicity worsening of renal function, hypertension,fluid retention, hyperkalaemia necrosis of renal papillae, interstitial nephritis, renal failure etc. -caused by the inhibition of renal cox-1 by NSAIDs(eg. fenoprofen) Appendix: Treatment aim ①relieve the acute Acute gout chronic gout gouty arthritis attack ②control the hyperuricemia reduce the serum level of uric acid Drug Mechanism (-) colchicine NSAIDs Indometh acin allopurinol probenecid inflammatio n (-) inflammation ↓uric acid synthesis ↑uric acid excretion Appendix: allopurinol purine xanthine oxidase uric acid probenecid excretion hyperuricemia NSAIDs joints kidney Other tissues arthritis Kidney damage Other tissue damages Indomethacin colchicine Drugs-induced interstitial nephritis Drugs-induced glomerular pathology A relatively uncommon condition which is characterised by inflammation of the renal tubules, glomeruli and surrounding tissue. Interstitial nephritis is usually be temporary and often associated with the use of a particular medication. Chronic and progressive forms do exist. Drugs that have been associated with interstitial nephritis include penicillins, ampicillin, cephalosporins, sulpha drugs, non-steroidal anti-inflammatory agents, furosemide and thiazide diuretics. May result in mild kidney dysfunction or acute renal failure. Treatment may be with corticosteroids. Glomerular pathology is less common than tubulointerstitial injury in druginduced nephrotoxicity. Prognosis. eg. NSAIDs Important causes of nephrotoxicity Gentamicin Aminoglycosides Pharmacokinetics Absorption: po poorly, im, iv Distribution : low concentration in most tissue except renal cortex Can pass placental barrier, ×BBB Excretion: in unchanged form by glomerular filtration Adverse reactions Dangerous factors: Using continuously more than 5 days High dose Eldly and children Renal insufficiency Concurrent use with loop diuretics or other nephrotoxic drugs cyclosporin Cyclic undecapeptide isolated from Tolypocladium inflatum, that has potent immunosuppressant activity on both humoral and cellular systems. The use of cyclosporin has made transplant surgery(eg.renal transplantation) much easier, although the long term consequences of suppressing immune function are not yet clear. Used widely as an an antirejection drug in transplant surgery and to prevent and treat rejection and graft-versushost disease in bone marrow transplant patients by suppressing their normal immune system. How cyclosporin nephrotoxicity is manifested Long term usage of Cyclosporin generally may results in Cyclosporin Nephrotoxicity Short term usage at high dosages can also cause Cyclosporin Nephrotoxicity Characterised by: Renal dysfunction Reduced GFR,Reduced renal blood flow, Rise in serum creatinine Decrease in renal clearance Rise in RAS, arteriolopathy of afferent arteriole vascular dysfunction and elevated BUN Non-prescription medicines eg.NSAIDs compound preparation Contrast agents eg.iodinated radiological contrast agents Nephrotoxicity Principle for treatment of renal damage early discovery, early diagnosis, timely withdrawal, timely treatment prevention first Diuretics Diuretics are a family of drugs that act on kidney and promote the excretion of urine (including water and electrolyte). (mainly used in edema) Classification of Diuretics Ⅰ. Loop (high efficacy diuretics) diuretics Ⅱ. Thiazide (moderate efficacy ) diuretics Ⅲ. Potassium-sparing (low efficacy) diuretics Ⅳ. Carbonic anhydrase inhibitors Ⅴ. Osmotic diuretics (dehydrants) Thank you